Abstract
This chapter will provide a general introduction to the kinetics of enzyme-catalyzed reactions, including a general discussion of catalysts, reaction rates, and binding constants. This section will be followed by a discussion of various types of enzyme kinetics observed in drug metabolism reactions. A large number of enzymatic reactions can be adequately described by Michaelis-Menten kinetics. The Michaelis-Menten equation represents a rectangular hyperbola, with a y-asymptote at the Vmax value. However, in other cases, more complex kinetic models are required to explain the observed data. Atypical kinetic profiles are believed to arise from the simultaneous binding of multiple molecules within the active site of the enzyme (Tracy and Hummel, Drug Metab Rev 36:231–242, 2004). Several cytochromes P450 (CYPs) have large active sites that enable binding of multiple molecules (Yano et al., J Biol Chem 279:38091–38094, 2004; Wester et al., J Biol Chem 279:35630–35637, 2004). Thus, atypical kinetics are not uncommon in in vitro drug metabolism studies.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Champe P, Harvey RA (1994) Lippincott’s illustrated reviews: biochemistry. J.B. Lippincott Company, Philadelphia, PA
Masterson W, Hurley C (1989) Chemistry: principles and reactions. Saunders College Publishing, Philadelphia, PA
Lehninger A, Nelson D, Cox M (1993) Principles of biochemistry. Worth Publishers, New York, NY
Stryer L (1993) Biochemistry. W.H. Freeman and Company, New York, NY
Creighton T (1993) Proteins: structures and molecular properties. W.H. Freeman and Company, New York, NY
Obach RS (2001) The prediction of human clearance from hepatic microsomal metabolism data. Curr Opin Drug Discov Devel 4:36–44
Pelkonen O, Turpeinen M (2007) In vitro-in vivo extrapolation of hepatic clearance: biological tools, scaling factors, model assumptions and correct concentrations. Xenobiotica 37:1066–1089. https://doi.org/10.1080/00498250701620726
Stenesh J (1993) Core topics in biochemistry. Cogno Press, Kalamazoo, Michigan
Segel I (1975) Enzyme kinetics: behavior and analysis of rapid equilibrium and steady state. Wiley, Hoboken, NJ
Gabrielsson J, Weiner D (2006) Pharmacokinetic & pharmacodynamic data analysis: concepts and applications. Swedish Pharmaceutical Press, Stockholm
Nath A, Atkins WM (2006) A theoretical validation of the substrate depletion approach to determining kinetic parameters. Drug Metab Dispos 34:1433–1435. https://doi.org/10.1124/dmd.106.010777
Obach RS, Reed-Hagen AE (2002) Measurement of Michaelis constants for cytochrome P450-mediated biotransformation reactions using a substrate depletion approach. Drug Metab Dispos 30:831–837. https://doi.org/10.1124/dmd.30.7.831
Tracy TS (2003) Atypical enzyme kinetics: their effect on in vitro-in vivo pharmacokinetic predictions and drug interactions. Curr Drug Metab 4:341–346. https://doi.org/10.2174/1389200033489280
Korzekwa KR, Krishnamachary N, Shou M et al (1998) Evaluation of atypical cytochrome P450 kinetics with two-substrate models: evidence that multiple substrates can simultaneously bind to cytochrome P450 active sites. Biochemistry 37:4137–4147. https://doi.org/10.1021/bi9715627
Tracy TS, Hummel MA (2004) Modeling kinetic data from in vitro drug metabolism enzyme experiments. Drug Metab Rev 36:231–242. https://doi.org/10.1081/dmr-120033999
Wei L, Locuson CW, Tracy TS (2007) Polymorphic variants of CYP2C9: mechanisms involved in reduced catalytic activity. Mol Pharmacol 72:1280–1288. https://doi.org/10.1124/mol.107.036178
Houston JB, Kenworthy KE, Galetin A (2003) Typical and atypical enzyme kinetics. In: Drug metabolizing enzymes: cytochrome P450 and other enzymes in drug discovery and development, 1st edn. Marcel Dekker, New York, NY, pp 211–254
von Moltke LL, Greenblatt DJ, Duan SX et al (1996) Phenacetin O-deethylation by human liver microsomes in vitro: inhibition by chemical probes, SSRI antidepressants, nefazodone and venlafaxine. Psychopharmacology 128:398–407. https://doi.org/10.1007/s002130050149
Venkatakrishnan K, von Moltke LL, Greenblatt DJ (1998) Human cytochromes P450 mediating phenacetin O-deethylation in vitro: validation of the high affinity component as an index of CYP1A2 activity. J Pharm Sci 87:1502–1507. https://doi.org/10.1021/js980255z
Tracy TS (2006) Atypical cytochrome p450 kinetics: implications for drug discovery. Drugs RD 7:349–363. https://doi.org/10.2165/00126839-200607060-00004
Hutzler JM, Tracy TS (2002) Atypical kinetic profiles in drug metabolism reactions. Drug Metab Dispos 30:355–362. https://doi.org/10.1124/dmd.30.4.355
Ekins S, Ring BJ, Binkley SN et al (1998) Autoactivation and activation of the cytochrome P450s. Int J Clin Pharmacol Ther 36:642–651
Fisher MB, Campanale K, Ackermann BL et al (2000) In vitro glucuronidation using human liver microsomes and the pore-forming peptide alamethicin. Drug Metab Dispos 28:560–566
Yano JK, Wester MR, Schoch GA et al (2004) The structure of human microsomal cytochrome P450 3A4 determined by X-ray crystallography to 2.05-A resolution. J Biol Chem 279:38091–38094. https://doi.org/10.1074/jbc.C400293200
Kenworthy KE, Clarke SE, Andrews J, Houston JB (2001) Multisite kinetic models for CYP3A4: simultaneous activation and inhibition of diazepam and testosterone metabolism. Drug Metab Dispos 29:1644–1651
Houston JB, Galetin A (2005) Modelling atypical CYP3A4 kinetics: principles and pragmatism. Arch Biochem Biophys 433:351–360. https://doi.org/10.1016/j.abb.2004.09.010
Galetin A, Clarke SE, Houston JB (2003) Multisite kinetic analysis of interactions between prototypical CYP3A4 subgroup substrates: midazolam, testosterone, and nifedipine. Drug Metab Dispos 31:1108–1116. https://doi.org/10.1124/dmd.31.9.1108
Hutzler JM, Kolwankar D, Hummel MA, Tracy TS (2002) Activation of CYP2C9-mediated metabolism by a series of dapsone analogs: kinetics and structural requirements. Drug Metab Dispos 30:1194–1200. https://doi.org/10.1124/dmd.30.11.1194
Lin Y, Lu P, Tang C et al (2001) Substrate inhibition kinetics for cytochrome P450-catalyzed reactions. Drug Metab Dispos 29:368–374
Zhang Z-Y, Wong YN (2005) Enzyme kinetics for clinically relevant CYP inhibition. Curr Drug Metab 6:241–257. https://doi.org/10.2174/1389200054021834
Zhou J, Tracy TS, Remmel RP (2010) Glucuronidation of dihydrotestosterone and trans-androsterone by recombinant UDP-glucuronosyltransferase (UGT) 1A4: evidence for multiple UGT1A4 aglycone binding sites. Drug Metab Dispos 38:431–440. https://doi.org/10.1124/dmd.109.028712
Motulsky H, Christopoulos A (2003) Fitting models to biological data using linear and nonlinear regression: a practical guide to curve fitting, GraphFit, Inc
Houston JB, Kenworthy KE (2000) In vitro-in vivo scaling of CYP kinetic data not consistent with the classical Michaelis-Menten model. Drug Metab Dispos 28:246–254
Tang W, Stearns RA, Kwei GY et al (1999) Interaction of diclofenac and quinidine in monkeys: stimulation of diclofenac metabolism. J Pharmacol Exp Ther 291:1068–1074
Egnell A-C, Houston B, Boyer S (2003) In vivo CYP3A4 heteroactivation is a possible mechanism for the drug interaction between felbamate and carbamazepine. J Pharmacol Exp Ther 305:1251–1262. https://doi.org/10.1124/jpet.102.047530
Lineweaver H, Burk D (1934) The determination of enzyme dissociation constants. J Am Chem Soc 56:658–666
Hofstee BH (1959) Non-inverted versus inverted plots in enzyme kinetics. Nature 184:1296–1298. https://doi.org/10.1038/1841296b0
Cornish-Bowden A (1979) Fundamentals of enzyme kinetics. Portland Press, London
Bevington P (1994) Data reduction and error analysis for the physical sciences. McGraw-Hill, Boston, MA
Akaike H (1974) A new look at the statistical model identification. IEEE Trans Autom Control 19:716–723
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Seibert, E., Tracy, T.S. (2021). Fundamentals of Enzyme Kinetics: Michaelis-Menten and Non-Michaelis–Type (Atypical) Enzyme Kinetics. In: Nagar, S., Argikar, U.A., Tweedie, D. (eds) Enzyme Kinetics in Drug Metabolism. Methods in Molecular Biology, vol 2342. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-1554-6_1
Download citation
DOI: https://doi.org/10.1007/978-1-0716-1554-6_1
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-1553-9
Online ISBN: 978-1-0716-1554-6
eBook Packages: Springer Protocols